The effects of short-term raloxifene therapy on fibrinolysis markers: TAFI, tPA, and PAI-1

---

Copy For Citation

OZEREN M., KARAHAN S., OZGUR M., EMINAGAOGLU S., Unsal M. A., BAYTAN S., ...More

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, vol.84, no.10, pp.987-991, 2005 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 84 Issue: 10
• Publication Date: 2005
• Doi Number: 10.1111/j.0001-6349.2005.00817.x
• Journal Name: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.987-991
• Çanakkale Onsekiz Mart University Affiliated: No

Abstract

Background. Markers of fibrinolysis, thrombin-activatable fibrinolysis inhibitor (TAFI), tissue-type plasminogen activator (tPA), and plasminogen activator inhibitor-1 (PAI-1) levels were studied for the evaluation of short-term effects of raloxifene administration in postmenopausal women.